AF
ARKG icon

Advisornet Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Advisornet Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94K Sell
70
-755
-92% -$24K ﹤0.01% 1870
2026
Q1 		$21.8K Hold
825
– – ﹤0.01% 1309
2025
Q4 		$23.9K Buy
825
+675
+450% +$20.3K ﹤0.01% 1268
2025
Q3 		$4.17K Hold
150
– – ﹤0.01% 1736
2025
Q2 		$3.65K Hold
150
– – ﹤0.01% 1740
2025
Q1 		$3.11K Sell
150
-145
-49% -$3.64K ﹤0.01% 1706
2024
Q4 		$6.95K Sell
295
-120
-29% -$2.95K ﹤0.01% 1405
2024
Q3 		$10.6K Sell
415
-100
-19% -$2.55K ﹤0.01% 1400
2024
Q2 		$12.1K Sell
515
-35
-6% -$883 ﹤0.01% 1246
2024
Q1 		$15.8K Buy
550
+137
+33% +$4.12K ﹤0.01% 1149
2023
Q4 		$13.5K Sell
413
-176
-30% -$4.79K ﹤0.01% 1228
2023
Q3 		$16.4K Buy
589
+70
+13% +$2.29K ﹤0.01% 1095
2023
Q2 		$17.7K Sell
519
-3
-0.6% -$94 ﹤0.01% 1137
2023
Q1 		$15.7K Sell
522
-117
-18% -$3.63K ﹤0.01% 1158
2022
Q4 		$18K Sell
639
-302
-32% -$9.59K ﹤0.01% 1089
2022
Q3 		$31K Hold
941
– – ﹤0.01% 978
2022
Q2 		$30K Sell
941
-956
-50% -$33.4K ﹤0.01% 1007
2022
Q1 		$87K Sell
1,897
-162
-8% -$7.72K 0.01% 794
2021
Q4 		$126K Sell
2,059
-534
-21% -$36.9K 0.01% 714
2021
Q3 		$194K Sell
2,593
-1,010
-28% -$84.7K 0.01% 590
2021
Q2 		$333K Buy
3,603
+1,157
+47% +$98.4K 0.02% 460
2021
Q1 		$217K Buy
2,446
+1,760
+257% +$175K 0.02% 541
2020
Q4 		$64K Buy
686
+450
+191% +$35.9K 0.01% 804
2020
Q3 		$15K Buy
+236
New +$13.8K ﹤0.01% 1163
2020
Q2 		– Sell
-1,142
Closed -$36K – 1762
2020
Q1 		$36K Buy
+1,142
New +$38.2K ﹤0.01% 897
2019
Q4 		– Sell
-1,500
Closed -$44K – 1838
2019
Q3 		$44K Buy
+1,500
New +$48.8K ﹤0.01% 949
2018
Q1 		– Sell
-1,500
Closed -$37K – 1398
2017
Q4 		$37K Buy
+1,500
New +$38K 0.01% 719

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Advisornet Financial's ARKG Position: Q2 2026 in Review

Advisornet Financial reduced its ARK Genomic Revolution ETF (ARKG) stake by 92% in Q2 2026, selling an estimated $24K and leaving 70 shares worth $2.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Advisornet Financial first reported a position in ARKG in Q4 2017 and has held it in 27 quarters since. The position peaked at $333K in Q2 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Advisornet Financial held 70 shares of ARK Genomic Revolution ETF worth $2.94K as of Q2 2026.
  • Advisornet Financial sold 755 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $24K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1870 holding.
  • Advisornet Financial first reported a position in ARK Genomic Revolution ETF in Q4 2017 and has held it in 27 quarters since.
  • Advisornet Financial's ARK Genomic Revolution ETF position peaked at $333K in Q2 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.